• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

APOL1-miR193a 轴的破坏导致足细胞肌动蛋白细胞骨架紊乱。

Disruption of APOL1-miR193a Axis Induces Disorganization of Podocyte Actin Cytoskeleton.

机构信息

Immunology and Inflammation Center, Feinstein Institute for Medical Research and Zucker School of Medicine at Hofstra-Northwell, New York, USA.

Ochsner Clinic, New Orleans, USA.

出版信息

Sci Rep. 2019 Mar 5;9(1):3582. doi: 10.1038/s41598-019-39376-y.

DOI:10.1038/s41598-019-39376-y
PMID:30837512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6401370/
Abstract

APOL1-miR193a axis participates in the preservation of molecular phenotype of differentiated podocytes (DPDs). We examined the hypothesis that APOL1 (G0) preserves, but APOL1 risk alleles (G1 and G2) disrupt APOL1-miR193a axis in DPDs. DPDG0s displayed down-regulation of miR193a, but upregulation of nephrin expression. DPDG1s/G2s exhibited an increase in miR193a and down-regulation of the expression of adherens complex's constituents (CD2AP, nephrin, and dendrin). DPDG0s showed decreased Cathepsin L, enhanced dynamin expressions, and the intact actin cytoskeleton. On the contrary, DPDG1s/G2s displayed an increase in Cathepsin L, but down-regulation of dynamin expressions and disorganization of the actin cytoskeleton. APOL1 silencing enhanced miR193a and Cathepsin L, but down-regulated dynamin expressions. DPDG1s/G2s displayed nuclear import of dendrin, indicating an occurrence of destabilization of adherens complexes in APOL1 risk milieu. These findings suggest that DPDG1s and DPDG2s developed disorganized actin cytoskeleton as a consequence of disrupted APOL1-miR193a axis. Interestingly, docking and co-labeling studies suggested an interaction between APOL1 and CD2AP. APOL1 and APOL1 transgenic mice displayed nuclear import of dendrin indicating destabilization of adherens complexes in podocytes; moreover, these mice showed a four-fold increase in urinary albumin to creatinine ratio and development of focal segmental glomerular lesions.

摘要

APOL1-miR193a 轴参与分化足细胞(DPD)分子表型的维持。我们检验了这样一个假设,即 APOL1(G0)保留,而 APOL1 风险等位基因(G1 和 G2)破坏了 DPD 中的 APOL1-miR193a 轴。DPDG0 显示 miR193a 下调,但肾素表达上调。DPDG1s/G2s 表现出 miR193a 增加和黏附复合物成分(CD2AP、肾素和 dendrin)表达下调。DPDG0 显示组织蛋白酶 L 减少,动力蛋白表达增强,肌动蛋白细胞骨架完整。相反,DPDG1s/G2s 显示组织蛋白酶 L 增加,但动力蛋白表达下调和肌动蛋白细胞骨架紊乱。APOL1 沉默增强了 miR193a 和组织蛋白酶 L,但下调了 dynamin 表达。DPDG1s/G2s 显示 dendrin 的核内输入,表明黏附复合物在 APOL1 风险环境中发生不稳定。这些发现表明,DPDG1s 和 DPDG2s 由于 APOL1-miR193a 轴的破坏而出现了紊乱的肌动蛋白细胞骨架。有趣的是,对接和共标记研究表明 APOL1 与 CD2AP 之间存在相互作用。APOL1 和 APOL1 转基因小鼠显示 dendrin 的核内输入,表明足细胞黏附复合物的不稳定;此外,这些小鼠的尿白蛋白/肌酐比值增加了四倍,并出现局灶节段性肾小球病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/48ad582c718f/41598_2019_39376_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/220eec0ebe80/41598_2019_39376_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/55f490219326/41598_2019_39376_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/6a24622be51c/41598_2019_39376_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/91244151756f/41598_2019_39376_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/b4e2edff7b73/41598_2019_39376_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/aac964406529/41598_2019_39376_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/84d9e5a57b36/41598_2019_39376_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/7bd833f416b6/41598_2019_39376_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/c53b36ca8225/41598_2019_39376_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/e09efb53e68a/41598_2019_39376_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/48ad582c718f/41598_2019_39376_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/220eec0ebe80/41598_2019_39376_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/55f490219326/41598_2019_39376_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/6a24622be51c/41598_2019_39376_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/91244151756f/41598_2019_39376_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/b4e2edff7b73/41598_2019_39376_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/aac964406529/41598_2019_39376_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/84d9e5a57b36/41598_2019_39376_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/7bd833f416b6/41598_2019_39376_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/c53b36ca8225/41598_2019_39376_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/e09efb53e68a/41598_2019_39376_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d304/6401370/48ad582c718f/41598_2019_39376_Fig11_HTML.jpg

相似文献

1
Disruption of APOL1-miR193a Axis Induces Disorganization of Podocyte Actin Cytoskeleton.APOL1-miR193a 轴的破坏导致足细胞肌动蛋白细胞骨架紊乱。
Sci Rep. 2019 Mar 5;9(1):3582. doi: 10.1038/s41598-019-39376-y.
2
Disrupted apolipoprotein L1-miR193a axis dedifferentiates podocytes through autophagy blockade in an APOL1 risk milieu.载脂蛋白 L1- miR193a 轴的紊乱通过自噬阻断在 APOL1 风险环境中使足细胞去分化。
Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C209-C225. doi: 10.1152/ajpcell.00538.2018. Epub 2019 May 22.
3
Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu.载脂蛋白 L1-微小 RNA-193a 轴的调节可防止高糖环境中足细胞去分化。
Am J Physiol Renal Physiol. 2018 May 1;314(5):F832-F843. doi: 10.1152/ajprenal.00541.2017. Epub 2018 Jan 10.
4
MiR193a Modulation and Podocyte Phenotype.miR193a 调控与足细胞表型。
Cells. 2020 Apr 17;9(4):1004. doi: 10.3390/cells9041004.
5
Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition.载脂蛋白 L1 在人顶泌汗腺上皮细胞转分化中的作用。
Am J Pathol. 2018 Nov;188(11):2508-2528. doi: 10.1016/j.ajpath.2018.07.025. Epub 2018 Sep 8.
6
Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype.携带 G2/G2APOL1 高危基因型的新型人足细胞细胞模型。
Cells. 2021 Jul 28;10(8):1914. doi: 10.3390/cells10081914.
7
APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.APOL1 风险变异通过增强内质网应激导致足细胞损伤。
Biosci Rep. 2018 Aug 29;38(4). doi: 10.1042/BSR20171713. Print 2018 Aug 31.
8
CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival.CD2AP 在小鼠和人足细胞中控制着一个蛋白水解程序,该程序调节细胞骨架结构和细胞存活。
J Clin Invest. 2011 Oct;121(10):3965-80. doi: 10.1172/JCI58552. Epub 2011 Sep 12.
9
[Role of CD2-associated protein in podocyte differentiation.].CD2相关蛋白在足细胞分化中的作用。
Sheng Li Xue Bao. 2008 Feb 25;60(1):135-42.
10
APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.APOL1-G0 可保护 HIV 相关肾病小鼠模型中的足细胞。
PLoS One. 2019 Oct 29;14(10):e0224408. doi: 10.1371/journal.pone.0224408. eCollection 2019.

引用本文的文献

1
APOL1 Dynamics in Diabetic Kidney Disease and Hypertension.载脂蛋白L1在糖尿病肾病和高血压中的动态变化
Biomolecules. 2025 Feb 1;15(2):205. doi: 10.3390/biom15020205.
2
APOL1 Modulates Renin-Angiotensin System.载脂蛋白L1调节肾素-血管紧张素系统。
Biomolecules. 2024 Dec 10;14(12):1575. doi: 10.3390/biom14121575.
3
Potential biomarkers of recurrent FSGS: a review.复发性局灶节段性肾小球硬化症的潜在生物标志物:综述。

本文引用的文献

1
Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition.载脂蛋白 L1 在人顶泌汗腺上皮细胞转分化中的作用。
Am J Pathol. 2018 Nov;188(11):2508-2528. doi: 10.1016/j.ajpath.2018.07.025. Epub 2018 Sep 8.
2
Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu.载脂蛋白 L1-微小 RNA-193a 轴的调节可防止高糖环境中足细胞去分化。
Am J Physiol Renal Physiol. 2018 May 1;314(5):F832-F843. doi: 10.1152/ajprenal.00541.2017. Epub 2018 Jan 10.
3
ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.
BMC Nephrol. 2024 Aug 12;25(1):258. doi: 10.1186/s12882-024-03695-8.
4
MicroRNA193a: An Emerging Mediator of Glomerular Diseases.miR-193a:肾小球疾病的新兴介质。
Biomolecules. 2023 Dec 4;13(12):1743. doi: 10.3390/biom13121743.
5
The metabolic effects of APOL1 in humans.APOL1 在人体中的代谢作用。
Pflugers Arch. 2023 Aug;475(8):911-932. doi: 10.1007/s00424-023-02821-z. Epub 2023 Jun 1.
6
Parietal Epithelial Cell Behavior and Its Modulation by microRNA-193a.顶泌汗腺上皮细胞行为及其受 microRNA-193a 的调控。
Biomolecules. 2023 Jan 31;13(2):266. doi: 10.3390/biom13020266.
7
The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.载脂蛋白 L1 肾病的演变故事:开端的结束。
Nat Rev Nephrol. 2022 May;18(5):307-320. doi: 10.1038/s41581-022-00538-3. Epub 2022 Feb 25.
8
Inhibition of endoplasmic reticulum stress signaling rescues cytotoxicity of human apolipoprotein-L1 risk variants in Drosophila.抑制内质网应激信号可挽救人载脂蛋白-L1 风险变异在果蝇中的细胞毒性。
Kidney Int. 2022 Jun;101(6):1216-1231. doi: 10.1016/j.kint.2021.12.031. Epub 2022 Feb 1.
9
Lessons From APOL1 Animal Models.载脂蛋白L1(APOL1)动物模型的经验教训。
Front Med (Lausanne). 2021 Oct 26;8:762901. doi: 10.3389/fmed.2021.762901. eCollection 2021.
10
Novel Human Podocyte Cell Model Carrying G2/G2 APOL1 High-Risk Genotype.携带 G2/G2APOL1 高危基因型的新型人足细胞细胞模型。
Cells. 2021 Jul 28;10(8):1914. doi: 10.3390/cells10081914.
载脂蛋白 L1 过表达驱动变异非依赖性细胞毒性。
J Am Soc Nephrol. 2018 Mar;29(3):869-879. doi: 10.1681/ASN.2016121322. Epub 2017 Nov 27.
4
Apolipoprotein L1 confers pH-switchable ion permeability to phospholipid vesicles.载脂蛋白L1赋予磷脂囊泡pH值可切换的离子通透性。
J Biol Chem. 2017 Nov 3;292(44):18344-18353. doi: 10.1074/jbc.M117.813444. Epub 2017 Sep 15.
5
A tripartite complex of suPAR, APOL1 risk variants and αβ integrin on podocytes mediates chronic kidney disease.足细胞上的suPAR、APOL1风险变异体和αβ整合素三方复合物介导慢性肾脏病。
Nat Med. 2017 Aug;23(8):945-953. doi: 10.1038/nm.4362. Epub 2017 Jun 26.
6
Effect of disease risk variants on gene product.疾病风险变异对基因产物的影响。
Biosci Rep. 2017 Apr 28;37(2). doi: 10.1042/BSR20160531. Print 2017 Apr 30.
7
Emerging Role of MicroRNAs in mTOR Signaling.微小RNA在mTOR信号通路中的新兴作用
Cell Mol Life Sci. 2017 Jul;74(14):2613-2625. doi: 10.1007/s00018-017-2485-1. Epub 2017 Feb 25.
8
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.足细胞中人类APOL1风险变异体的转基因表达可诱发小鼠肾病。
Nat Med. 2017 Apr;23(4):429-438. doi: 10.1038/nm.4287. Epub 2017 Feb 20.
9
APOL1-Mediated Cell Injury Involves Disruption of Conserved Trafficking Processes.APOL1介导的细胞损伤涉及保守运输过程的破坏。
J Am Soc Nephrol. 2017 Apr;28(4):1117-1130. doi: 10.1681/ASN.2016050546. Epub 2016 Nov 18.
10
APOL1-G1 in Nephrocytes Induces Hypertrophy and Accelerates Cell Death.肾细胞中的载脂蛋白L1 G1型诱导肥大并加速细胞死亡。
J Am Soc Nephrol. 2017 Apr;28(4):1106-1116. doi: 10.1681/ASN.2016050550. Epub 2016 Nov 18.